Document qKRG801085Vw8BZN9rko7KVj

Benzene Health Research Consortium Technical Committee Dra.ft Minutes Conference Call - 18 Nov 2004 Participants Patrick Beatty (ChevronTexaco) Steve Bose (ExxonMobil) Don Burnett (BP) Stuart Cagen (Shell) Jennifer Galvin (ConocoPhillips) Howard Feldman (API; part-time) Bruce Jarnot (API) Administrative Items Call was conducted in accordance with API antitrust guidelines Agenda: discuss I review "action items" generated at early-November OC meeting in Houston o Expectation to provide update(s) by 10 December 2004 Background Most Action Items can likely be met by PI discussion(s) $3.3MM gap identified by Pis o OC deferred most action items to the TC o Funding required to carry the studies to completion o o Possible BP $1.7MM added contribution? o o Need better understanding of basis of the gap General Discussion Items ActiOn - Prioritization under current funding? (Alternate approach, still pending ...) o Prioritization by SRP/ERP o Prioritization by Pis? Draft Minutes for Review Page 1of3 SHELL-MCCLURG-057021 Benzene Health Research Consortium Technical Committee Meeting Notes o o OC has ID'ed -$600K possible cost savings ("sweat equity" approach) Added cost of exposu re assessment o How much of Yimei's costs embedded in Richard's re-analysis? 2-month (longer?) replacement for Patrick not ID'ed (ChevronTexaco) o Patrick will be on short term disability starting end-of-December _ : Discuss "Action Items" in-person with Richard o ActiOn: Patrick/Stuart to call or email regarding possible meeting Long-standing Action Items AoHOn: Review Munich attendee list for possible scientific involvement follow-up o AoHOn: Do we need a formal QA/QC audit of Shanghai? o _ : affirm recommendation that this -$1 OOK line-item be dropped o QA/QC will be internally covered by JCML lab accreditation o _ : TC delegation to visit lab operations New Action Items Nat Rothman (NCI Investigator) proposed NCI/Consortium collaboration o NCI China CC Study proposed, beginning 2007 mctloO:o TC to discuss NCI's offer with PI's o _ : include in PI discussions AbtibR: options for JCML continuation, via outside funding? o Contingent upon Fudan plans ... o Continue within School of Public Health o Or establish JCML as separate, free-standing department Draft Minutes for Review Page 2 of3 SH ELL-MCCLU RG-057022 Benzene Health Research Consortium Technical Committee Meeting Notes o Fudan decision possible by end-of-year o _ : Ask Richard if he sees value in having Company rep's meeting with Fudan o _ : include in PI discussions ActiOt): confirm Budget Re-analyses as being complete & comprehensive o Anything overlooked (e.g., Richard T&E cost increase) o Any "cost overlap" (e.g., Yimei's time-in-field in Richard's re-analysis vs. EMBSI funding her effort) o _ : include in PI discussions ActiOn: reality check of exposure assessment o Do we need more than a yes/no for CC exposures? o o _ : check w/ SRP & Pis ... can we cut back on level of assessment? o _ : include in PI discussion 1. Pis to reconsider "what can really be done" in exposure assessment?" 2. Will this provide some of the answers Draft Minutes for Review Page 30f3 SH ELL-MCCLU RG-057023